Business Context and Reporting Period
Oragenics, Inc. filed a Form 8-K Current Report on September 15, 2016. The filing discloses the entry into a material definitive agreement involving an amendment to an existing unsecured promissory note.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, or operating margins. The primary financial data relates to a specific debt instrument:
- Principal Amount: $2,000,000
- Lender: Koski Family Limited Partnership (KFLP)
- Original Maturity Date: September 30, 2016
- Original Interest Rate: 3% per annum
Material Changes
On September 15, 2016, the Company amended the June 30, 2016 promissory note with the following changes, contingent upon the KFLP paying at least $1,000,000 towards principal and accrued interest by September 30, 2016:
- Maturity Extension: The maturity date was extended from September 30, 2016, to December 31, 2016.
- Interest Rate Increase: The interest rate increased from 3% to 6% per annum, effective September 30, 2016.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general business risks. The primary contingency noted is the requirement for the KFLP to make a payment of at least $1,000,000 by September 30, 2016, for the amended terms (extension and rate increase) to become effective.
Investor Verification Checklist
- Verify whether the KFLP made the required $1,000,000 payment by September 30, 2016, to trigger the maturity extension and interest rate increase.
- Review the full text of Amendment No. 1 (Exhibit 10.2) for any additional covenants or conditions not summarized here.
- Assess the Company's overall liquidity position given the extension of this $2,000,000 debt obligation.